Strategic integration of knowledge in Indian pharmaceutical firms: creating competencies for innovation

International Journal of Business Innovation and Research

Volumn 1, Issue 1-2, 2006, Pages 27-50

  Chaturvedi, Kalpana ^a   Chataway, Joanna ^a  

^a OPEN UNIVERSITY   (United Kingdom)

Author keywords

Indian pharmaceutical firms; innovation competencies; knowledge; strategies

Indexed keywords

EID: 34548568556     PISSN: 17510252     EISSN: 17510260     Source Type: Journal    
DOI: 10.1504/ijbir.2006.011087     Document Type: Article

References (43)

1. Bower, J.D. and Sulej, J. (2005) ‘The Indian challenge: the evolution of a successful new global strategy in the pharmaceutical industry’, Innogen Working Paper, No. 21.
2. Chiesa, V. and Toletti, G. (2004) ‘Network of collaborations for innovation: the case of biotechnology’, Technology Analysis and Strategic Management, Vol. 16, No. 1, pp.73–96.
3. Cohen, W. and Levinthal, D. (1990) ‘Absorptive capacity: a new perspective on learning and innovation’, Administrative Science Quarterly, Vol. 35, pp.128–152.
4. Company Interviews and Annual Reports (2000-2004).
5. Correa, C.M. (2000) Integrating Public Health Concerns into Patent Legislation in Developing Countries, University of Buenos Aires, Argentina, South Centre.
6. Freeman, C. and Perez, C. (1988) ‘A structural crises of adjustment: business cycles and investment behaviour’, in G. Dosi et al. (Eds.) Technical Change and Economic Theory, London and New York: Columbia University Press.
7. Halemane, M.D. and Dongen, B. (2003) ‘Strategic innovation management of change in the pharmaceutical industry’, International Journal of Technology Management, Vol. 25, Nos. 3-4, pp.314–333.
8. India Folio (2004) Embassy of India, Copenhagen, Vol. 5, No. 8.
9. Journal of Intellectual Property Rights (various issues) NISCAIR, New Delhi, India.
10. Justice Ayyangar, N.R. (1959) Report on the Revision of the Patent Laws, Government of India, New Delhi.
11. Kefauver Senate Committee Report (1962) in Hamied Y.K. (1993) ‘Patents and the pharmaceutical industry: a review’, Presented in the International Conference on Patent Regime Proposed in the Uruguay Round, New Delhi, 2-4 September.
12. Keller, R. (2004) ‘A resource-based study of new product development: predicting five year later commercial success and speed to market’, International Journal of Innovation Management, Vol. 8, No. 3, pp.243–260.
13. Kim, L. (1997) Imitation to Innovation: The Dynamics of Korea’s Technological Learning, Boston, MA: Harvard Business School Press.
14. Kumar, N. (2002) ‘Intellectual property rights, technology and economic development; experiences of Asian countries’, RIS Discussion Paper #25/2002, RIS: New Delhi.
15. Lall, S. (1984) ‘India’s technological capacity: effects of trade, industrial, science and technology policies’, in M. Fransman and K. King (Eds.) Technological Capability in the Third World, London: Macmillan, pp.225–244.
16. Lanjouw, J.O. (1997) ‘The introduction of pharmaceutical product patents in India: heartless exploitation of the poor and suffering?’, Center Discussion Paper, Yale University and the NBER, No. 775.
17. Lee, W.Y. (2000) ‘The role of science and technology policy in Korea’s industrial development’, in L. Kim and R.R. Nelson (Eds.) Technology, Learning and Innovation: Experience of Newly Industrialized Economies, Cambridge University Press, pp.269–290.
18. Leonard-Barton, D. (1992) ‘Core capabilities and core rigidities: a paradox in managing new product development’, Strategic Management Journal, Vol. 13, pp.111–125.
19. Madanmohan, T.R. and Krishnan, K.T. (2003) ‘Adaptive strategies in the Indian pharmaceutical industry’, International Journal of Technology Management, Vol. 20, Nos. 3-4, pp.227–246.
20. Malerba, F. and Orsenigo, L. (2001) ‘Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a history friendly model’, Paper Presented at the DRUID Nelson and Winter Conference, Aalborg, 12-15 June.
21. National Council of Applied Economic Research (NCAER) (1984) ‘Indian pharmaceutical industry: problems and prospects’, A Report Published by the National Council of Applied Economic Research (NCAER), New Delhi.
22. Nelson, R. and Winter, S. (1977) ‘In search of useful theory of innovation’, Research Policy, Vol. 6, pp.36–76.
23. OPPI (2003) Outsourcing Opportunities in Indian Pharmaceutical Industry, OPPI and Monitor Company Group, LP.
24. Pavitt, K. (1990) ‘What do we know about the strategic management of technology?’, California Management Review, Vol. 32, No. 3, pp.17–26.
25. Penrose, E.T. (1959) The Theory of the Growth of the Firm, Oxford: Basil Blackwell.
26. Porter, M.E. (1990) The Competitive Advantage of Nations, London: Macmillan.
27. Rasiah, R. (2002) ‘TRIPs and capability building in developing economies’, The UNU/INTECH Discussion Paper Series # 2002—1.
28. Rosenberg, N. (1969) ‘The direction of technological change: inducement mechanisms and focusing devices’, Economic Development and Cultural Change, Part 1, Vol. 18, No. 1, pp.1–24.
29. Sakakibara, M. and Dodgson, M. (2003) ‘Strategic research partnerships: empirical evidence from Asia’, Technology Analysis and Strategic Management, Vol. 15, No. 2, pp.227–245.
30. Schumpeter, J.A. (1947) Capitalism, Socialism and Democracy, 2nd ed., New York: Harper and Row.
31. Selznick, P. (1957) Leadership in Administration: A Sociological Interpretation, New York: Harper and Row.
32. Smith, S.E. (2000) ‘Opening up to the world: India’s pharmaceutical companies prepare for 2005’, Occasional Paper, Asia/Pacific Research Center, Institute for International Studies, Stanford University.
33. Teece, D.J., Pisano, G. and Sheun, A. (1997) ‘Dynamic capabilities and strategic management’, Strategic Management Journal, Vol. 18, No. 7, pp.509–533.
34. Watal, J. (2000) ‘Pharmaceutical patents, prices and welfare losses: policy options for India under the WTO TRIPs agreement’, The World Economy, Vol. 23, No. 5, pp.733–752.
35. Zaveri, N.B. (2002) Doha to Delhi – A Retreat on Healthcare, Mumbai: Ebenezer Printing House.
36. Coombs, R. and Richards, A. (1991) ‘Technologies, products and firms’ strategies Part I – A framework for analysis’, Technology Analysis and Strategic Management, Vol. 3, No. 1, pp.77–86.
37. Hobday, M. (2002) ‘A review of firm level innovation models in industrially advanced countries: implications for Korea’, in Y.H. Ho, S. Song, D.H. Lee and M. Hobday (Eds.) Technological Innovation of Korean Firms, STEPI, Seoul, Korea, Chap. 2, pp.11–58.
38. Indian Drugs Manufacturers Association (various years) Annual Publication, IDMA, Mumbai.
39. Kumar, N. (1997) ‘Technology generation and technology transfer in the world economy: recent trends and implications for developing countries’, The UNU/INTECH Discussion Paper Series # 9702.
40. Leonard-Barton, D. (1995) Wellsprings of Knowledge: Building and Sustaining the Sources of Innovation, Boston, MA: Harvard Business School Press.
41. Pavitt, K. (2002) ‘Innovative routines in the business firm: what corporate tasks should they be accomplishing?’, Industrial and Corporate Change, Vol. 11, No. 1, pp.117–133.
42. Teece, D.J. (1986) ‘Profiting from technological innovation: implications for integration, collaboration, licensing and public policy’, Research Policy, Vol. 15, pp.285–305.
43. Tidd, J., Bessant, J. and Pavitt, K. (1997) Managing Innovation: Integrating Technological, Market and Organisational Change, Chichester: Wiley.